The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Allergy: European Journal of Allergy and Clinical Immunology - Tập 69 Số 7 - Trang 868-887 - 2014
Torsten Zuberbier1, Werner Aberer2, Riccardo Asero3, Carsten Bindslev‐Jensen4, Zenon Brzoza5, Giorgio Walter Canonica6, Martin K. Church1, Luís Felipe Ensina7, Ana M. Giménez‐Arnau8, Kiran Godse9, Margarida Gonçalo10, Clive Grattan11, Jean‐Louis Hébert12, Kazumasa Iwamoto13, Allen P. Kaplan14, Alexander Kapp15, Amir Hamzah Abdul Latiff16, P. Mathelier‐Fusade17, Martin Metz1, Alexander Nast1, Sarbjit S. Saini18, Mario Sánchez‐Borges19, Peter Schmid‐Grendelmeier20, F. Estelle R. Simons21, Petra Staubach22, Gordon Sussman23, Elias Toubi24, Gino Antonio Vena25, Bettina Wedi15, X. J. Zhu26, Marcus Maurer1
1Department of Dermatology and Allergy Allergy‐Centre‐Charité Charité – University Hospital Berlin Berlin Germany
2Department of Dermatology, Medical University of Graz, Graz, Austria
3Allergy Clinic Clinica San Carlo Paderno Dugnano MI Italy
4Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark
5Department of Internal Diseases, Allergology and Clinical Immunology in Katowice; Medical University of Silesia; Zabrze Poland
6Respiratory Diseases & Allergy, University of Genoa, IRCCS AOU SanMartino, Genoa, Italy
7Department of Clinical Immunology and Allergy, Federal University of Sao Paulo, Sao Paulo, Brazil
8Hospital del Mar. Parc de Salut Mar Universitat Autònoma Barcelona Barcelona Spain
9Department of Dermatology Dr. D. Y. Patil Medical College & Hospital Nerul Navi Mumbai India
10Clinic of Dermatology Faculty of Medicine and University Hospital Coimbra Portugal
11St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, UK.
12Center for Applied Research on Allergy Québec Québec QC Canada
13Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
14Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology Department of Medicine Medical University of South Carolina Charleston SC USA
15Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
16Department of Paediatrics; Pantai Hospital Kuala Lumpur; Bangsar Kuala Lumpur Malaysia
17Department of Dermatology and Allergy University Hospital of Tenon Paris France
18Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA
19Allergy and Clinical Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela
20Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
21Departments of Pediatrics & Child Health, Immunology University of Manitoba Winnipeg MB Canada
22Department of Dermatology, University Medical Center Mainz, Mainz, Germany
23Division of Allergy and Clinical Immunology University of Toronto Toronto ON Canada
24Bnai-Zion Medical Center Faculty of Medicine Technion Haifa Israel
25Unit of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy
26Department of Dermatology, Peking University First Hospital, Beijing, China

Tóm tắt

Abstract

This guideline is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU‐funded network of excellence, the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell‐driven disease, presenting with wheals, angioedema, or both. The life‐time prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence‐based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

Từ khóa


Tài liệu tham khảo

10.1111/j.1398-9995.2009.02179.x

10.1111/j.1398-9995.2009.02178.x

10.1046/j.0022-202x.2001.00022.x

10.1046/j.0022-202x.2001.00023.x

10.1111/j.1398-9995.2005.00962.x

10.1111/j.1398-9995.2005.00964.x

10.1136/bmj.39493.646875.AE

10.1136/bmj.39490.551019.BE

10.1136/bmj.39489.470347.AD

10.1111/j.1398-9995.2007.01560.x

10.1164/rccm.200602-197ST

10.1159/000023902

10.1097/00000372-198912000-00003

10.1111/j.1398-9995.2011.02570.x

10.1159/000237648

10.1016/S0091-6749(99)70506-3

10.1056/NEJM199506293322608

10.1056/NEJMcp011186

10.1111/j.1398-9995.2011.02580.x

10.1046/j.1365-2133.1997.d01-1168.x

10.1034/j.1398-9995.2003.00091.x

10.1046/j.1365-2133.1999.02767.x

10.1111/j.1398-9995.2005.00833.x

10.1111/j.1398-9995.2011.02695.x

10.1111/j.1398-9995.2008.01920.x

Valero A, 2008, Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU‐Q2oL), J Investig Allergol Clin Immunol, 18, 426

10.2340/00015555-1199

Brzoza Z, 2011, Adaptation and initial results of the Polish version of the GA2LEN chronic urticaria quality of life questionnaire (CU‐Q(2)oL), J Dermatol Sci, 62, 36

10.1111/all.12209

10.1111/j.1398-9995.2008.01726.x

10.1016/j.anai.2011.09.008

Zuberbier T, 2007, Urticaria: current opinions about etiology, diagnosis and therapy, Acta Derm Venereol, 87, 196, 10.2340/00015555-0240

Magerl MA, 2008, Urticaria – classification and strategies for diagnosis and treatment, CME Dermatol, 3, 2

10.1159/000339869

10.1097/01.all.0000168795.12701.fd

10.1111/j.1365-2133.1981.tb15306.x

Zuberbier T, 1995, Pseudoallergen‐free diet in the treatment of chronic urticaria – a prospective study, Acta Derm Venereol, 75, 484, 10.2340/0001555575484487

10.1056/NEJM199306033282204

10.1172/JCI511

10.1111/j.1398-9995.2004.00631.x

10.1097/00130832-200410000-00010

10.1159/000023958

10.2165/00128071-200203040-00005

10.1371/journal.pone.0014794

10.1111/j.1398-9995.2009.02177.x

10.1080/00015550252948167

10.1001/archdermatol.2011.682

10.1046/j.1365-2133.1999.02707.x

10.1046/j.1365-2222.2001.01131.x

10.1016/S1081-1206(10)62384-8

10.1067/mai.2002.121314

10.1016/j.jaci.2008.11.040

10.1111/j.1468-3083.2006.01852.x

10.1159/000096079

10.1016/j.rmed.2007.07.010

10.1111/j.1365-2222.2005.02227.x

10.1111/j.1365-2133.1986.tb04065.x

10.1111/1523-1747.ep12338544

10.1016/S0091-6749(99)70190-9

10.1159/000071486

10.1159/000075251

10.1111/j.1398-9995.2009.02132.x

10.1159/000292947

10.1016/j.jaci.2004.07.018

10.1111/j.1365-2133.2009.09441.x

10.1111/ced.12107

10.1016/j.iac.2004.01.006

Gimenez‐Arnau A, 2010, Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis – “A Never Ending Story”, Eur J Dermatol, 20, 552

10.1046/j.1365-2222.2003.01589.x

10.1038/jid.2008.55

10.1097/MOP.0b013e328305e262

Novembre E, 2008, Urticaria and urticaria related skin condition/disease in children, Eur Ann Allergy Clin Immunol, 40, 5

10.1111/j.1398-9995.1998.tb03817.x

10.1111/j.1525-1470.1990.tb00663.x

10.1034/j.1398-9995.2000.00116.x

10.1016/j.jaci.2009.06.027

10.1016/j.jaci.2010.07.019

10.1385/CRIAI:30:1:019

10.1097/ACI.0b013e32833c79d7

10.1186/1710-1492-5-10

10.1046/j.1365-4362.1998.00328.x

10.1023/A:1018851623109

10.1111/j.1365-4632.2005.02280.x

Henz BM, 1998, Urticaria – clinical, diagnostic and therapeutic aspects, 19

10.1111/j.1365-2133.1969.tb16041.x

Bruno G, 1998, Proceedings of the International Symposium on Urticaria, 85

10.1016/0140-6736(92)90666-Q

10.1016/S0091-6749(96)80958-4

10.1034/j.1398-9995.2000.00317.x

10.1111/j.1365-2222.2008.03110.x

10.1007/s00403-011-1203-3

10.1111/j.1365-2133.2004.06095.x

10.1067/mjd.2000.104517

10.1111/j.1398-9995.2008.01913.x

10.2340/00015555-1434

10.1016/j.coi.2008.09.005

10.1111/j.1398-9995.2009.02325.x

10.1111/j.1398-9995.2007.01620.x

10.1002/hup.1184

10.1007/BF00637746

10.1159/000246281

Kontou‐Fili K, 1989, Therapeutic effect of cetirizine 2 HCl in delayed pressure urticaria, Health Sci Rev, 3, 23

10.1016/0091-6749(71)90083-2

10.1016/0091-6749(75)90078-0

10.1016/j.jaci.2009.11.047

10.1016/j.jaci.2008.12.008

10.1111/j.1468-3083.2009.03289.x

10.1016/S1081-1206(10)60644-8

10.4168/aair.2012.4.6.326

10.1097/ACI.0b013e328355365a

10.1159/000336205

10.1111/j.1346-8138.2011.01473.x

10.4103/0019-5154.84737

10.1016/j.jaci.2010.05.047

10.1016/j.jaci.2007.12.1121

10.1016/j.jaci.2011.06.010

10.1016/j.jaci.2011.04.038

10.1111/j.1398-9995.2010.02472.x

10.1111/j.1398-9995.2007.01591.x

10.1016/j.jaci.2006.04.003

10.1111/j.1398-9995.2008.01879.x

10.1111/j.1398-9995.2009.02268.x

10.1111/j.1398-9995.2010.02409.x

10.1111/j.1398-9995.2009.02188.x

10.1159/000320233

10.1016/j.jaci.2011.06.010

10.1111/1523-1747.ep12499960

10.1038/sj.bjp.0707002

10.1046/j.1365-2133.2000.03664.x

10.1016/j.jaad.2006.04.078

10.1111/j.1525-1470.2009.00869.x

Zuberbier T, 1996, Acute urticaria: clinical aspects and therapeutic responsiveness, Acta Derm Venereol, 76, 295, 10.2340/0001555576295297

Asero R, 2010, Usefulness of a short course of oral prednisone in antihistamine‐resistant chronic urticaria: a retrospective analysis, J Investig Allergol Clin Immunol, 20, 386

10.1016/j.jaci.2006.12.658

10.1046/j.1365-2133.1998.02033.x

10.1046/j.1365-2133.2003.05486.x

Pereira C, 2007, Low‐dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria, Eur Ann Allergy Clin Immunol, 39, 237

10.1016/j.anai.2009.12.007

10.1111/j.1468-3083.2011.04098.x

Hannuksela M, 1985, Ultraviolet light therapy in chronic urticaria, Acta Derm Venereol, 65, 449, 10.2340/0001555565449450

10.1016/j.jaad.2008.07.016

Engin B, 2008, Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial, Acta Derm Venereol, 88, 247, 10.2340/00015555-0434

10.1111/j.1398-9995.1980.tb01728.x

Laurberg G, 1977, Tranexamic acid (Cyklokapron) in chronic urticaria: a double‐blind study, Acta Derm Venereol, 57, 369, 10.2340/0001555557369370

10.1159/000248580

10.1111/j.1365-2133.1989.tb04167.x

10.1016/S0190-9622(88)70137-1

10.1016/j.reprotox.2008.05.053

10.2165/00002018-200831090-00006

ZuberbierT AbererW AseroR Bindslev‐JensenC BrzozaZ CanonicaGWet al.Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO Guideline for the definition classification diagnosis and management of urticaria.2014;69:e1–e29.

Thông tin
Thông tin xuất bản

Allergy: European Journal of Allergy and Clinical Immunology

Tập 69 Số 7

868-887

Thông tin tác giả